Daphne Taylor
CIK: 0001393549
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Aptevo Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 6, 2026APVO
Aptevo Therapeutics Inc.
Exercise(M)Direct638 shares- - Aug 6, 2025APVO
Aptevo Therapeutics Inc.
Award(A)DirectRestricted Stock Unit
11.5K shares- - Jul 17, 2025APVO
Aptevo Therapeutics Inc.
Exercise(M)Direct3 shares- - Mar 4, 2025APVO
Aptevo Therapeutics Inc.
Exercise(M)Direct1 shares- - Mar 2, 2025APVO
Aptevo Therapeutics Inc.
Exercise(M)Direct2 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 6, 2026 | APVO Aptevo Therapeutics Inc. | Exercise(M) | 638 | - | $0 | Direct |
| Aug 6, 2025 | APVO Aptevo Therapeutics Inc. | Award(A) Restricted Stock Unit | 11,500 | - | - | Direct |
| Jul 17, 2025 | APVO Aptevo Therapeutics Inc. | Exercise(M) | 3 | - | - | Direct |
| Mar 4, 2025 | APVO Aptevo Therapeutics Inc. | Exercise(M) | 1 | - | - | Direct |
| Mar 2, 2025 | APVO Aptevo Therapeutics Inc. | Exercise(M) | 2 | - | - | Direct |
1-5 of 5 transactions
About Taylor Daphne
Taylor Daphne (SEC CIK 0001393549) files insider reports with the SEC as SVP, CFO of Aptevo Therapeutics Inc. (APVO).
Signal8 holds 4 ownership filings by Taylor Daphne, all Form 4s, filed between Mar 4, 2025 and Aug 10, 2026. Those filings report 5 transactions, from Mar 2, 2025 to Aug 6, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Taylor Daphne's filings is in SEATTLE, WA.
Recent filings by Taylor Daphne
- Aug 6, 2026: Option exercise of APVO shares (Form 4, code M).
- Aug 6, 2025: Grant or award of APVO derivative securities (Form 4, code A).
- Jul 17, 2025: Option exercise of APVO shares (Form 4, code M).
- Mar 4, 2025: Option exercise of APVO shares (Form 4, code M).
- Mar 2, 2025: Option exercise of APVO shares (Form 4, code M).
Other insiders filing for Aptevo Therapeutics Inc. (APVO)
- Harsanyi Zsolt, Director
- Lamothe Jeffrey G., President and CEO
- Kwon SoYoung, SVP, GC, BD & Corp Affairs
- Huebner Dirk, SVP, CMO
- Grant Grady III, Director
- White Marvin L, Executive Chair